Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nomir Medical Technologies, a medical device company, has announced that the European Patent Office has granted a patent to the company which protects its core Noveon technology.
Subscribe to our email newsletter
The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.
The patent coverage provides for use of two proprietary near-infrared wavelengths that have proven to damage and eradicate bacteria and fungi in human diseased tissue ranging from onychomycosis to methicillin-resistant Staphylococcus aureus infection in the human nose, without thermal injury to surrounding tissues.
The patent has broad coverage through apparatus claims, including general bacterial infections, specialty optical clips for fingers and toes, hand pieces, root-canal tips, dental scalers, and otoscopes, the company said.
Richard Burtt, president and CEO of Nomir Medical, said: “This new European patent contains broad claims that cover many of the unique and important characteristics in our Noveon system, and adds to our substantial photobiology portfolio. We remain committed to innovation that furthers our core technology and protects our position in the field of anti-infective optical technologies.”